Coronavirus Disease 2019 (COVID-19) Update

Coronavirus Disease 2019 (COVID-19) Update

FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last email update include:

Coronavirus (COVID-19) Updates:

• May 19, 2020: Daily Roundup: FDA actions on diagnostics, succinylcholine chloride injection approval and more
• May 19, 2020: USDA, FDA Strengthen U.S. Food Supply Chain Protections
• May 19, 2020: FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response
• May 18, 2020: FDA Voices: COVID-19 Supply Chain Update: Importation of Vital Food and Medical Products
• May 16, 2020: FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
• May 14, 2020: FDA Informs Public About Possible Accuracy Concerns with Abbott ID NOW Point-of-Care Test
• May 14, 2020: Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19

Coronavirus Testing Basics

You’ve probably heard a lot about coronavirus testing recently. If you think you have coronavirus disease 2019 (COVID-19) and need a test, contact your health care provider immediately. The FDA has been working around the clock to increase the availability of critical medical products, including tests for the coronavirus, to fight the COVID-19 pandemic. Learn more about the different types of tests and the steps involved. (Also available as a printable PDF). Learn more on our website.

Find additional coronavirus disease 2019 (COVID-19) updates on our website and in the Medical Countermeasures Initiative newsletter.